10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2017 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 27, 2018) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Revenues | |||
| Product sales | $ 25,662 | 29,953 | 32,151 |
| Royalty, contract and other revenues | 445 | 437 | 488 |
| Total revenues | 26,107 | 30,390 | 32,639 |
| Costs and Expenses | |||
| Cost of goods sold | 4,371 | 4,261 | 4,006 |
| Research and development expenses | 3,734 | 5,098 | 3,014 |
| Selling, general and administrative expenses | 3,878 | 3,398 | 3,426 |
| Total costs and expenses | 11,983 | 12,757 | 10,446 |
| Income from operations | 14,124 | 17,633 | 22,193 |
| Interest expense | (1,118) | (964) | (688) |
| Other income (expense), net | 523 | 428 | 154 |
| Income before provision for income taxes | 13,529 | 17,097 | 21,659 |
| Provision for income taxes | 8,885 | 3,609 | 3,553 |
| Net income | 4,644 | 13,488 | 18,106 |
| Net income (loss) attributable to noncontrolling interest | 16 | (13) | (2) |
| Net income attributable to Gilead | 4,628 | 13,501 | 18,108 |
| Net income per share attributable to Gilead common stockholders - basic | 3.54 | 10.08 | 12.37 |
| Shares used in per share calculation - basic | 1,307 | 1,339 | 1,464 |
| Net income per share attributable to Gilead common stockholders - diluted | 3.51 | 9.94 | 11.91 |
| Shares used in per share calculation - diluted | 1,319 | 1,358 | 1,521 |
| Cash dividends declared per share | 2.08 | 1.84 | 1.29 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |